Blockade of CD354 (TREM-1) Ameliorates Anti-GBM-Induced Nephritis.
Du Y, Wu T, Zhou XJ, Davis LS, Mohan C.
Inflammation. 2016 Jun;39(3):1169-76. doi: 10.1007/s10753-016-0351-1.
Rapidly progressive glomerulonephritis in children.
Moorani KN, Aziz M, Amanullah F.
Pak J Med Sci. 2022 Jan;38(2):417-425. doi: 10.12669/pjms.38.ICON-2022.5774.
Rituximab in treatment of anti-GBM antibody glomerulonephritis: A case report and literature review.
Uematsu-Uchida M, Ohira T, Tomita S, Satonaka H, Tojo A, Ishimitsu T.
Medicine (Baltimore). 2019 Nov;98(44):e17801. doi: 10.1097/MD.0000000000017801.
Update on crescentic glomerulonephritis.
Hénique C, Papista C, Guyonnet L, Lenoir O, Tharaux PL.
Semin Immunopathol. 2014 Jul;36(4):479-90. doi: 10.1007/s00281-014-0435-7. Epub 2014 Jun 20.
Treatment of non anti-GBM-antibody mediated, rapidly progressive glomerulonephritis by plasmapheresis and immunosuppression.
Müller GA, Seipel L, Risler T.
Klin Wochenschr. 1986 Mar 3;64(5):231-8. doi: 10.1007/BF01711654.
Coexistence of double seropositivity for MPO antibody and anti-GBM antibody in ANCA-associated vasculitis concurrent with multiple myeloma: A case report.
Lee H, Yang J, Kwon J, Heo M, Kim Y, Paek JH, Shin H, Choe M, Han S, Jin K.
Medicine (Baltimore). 2024 Jul 26;103(30):e39021. doi: 10.1097/MD.0000000000039021.
Anti-glomerular basement membrane antibody-mediated nephritis complicating transplantation in a patient with Alport's syndrome.
Fleming SJ, Savage CO, McWilliam LJ, Pickering SJ, Ralston AJ, Johnson RW, Ackrill P.
Transplantation. 1988 Dec;46(6):857-9. doi: 10.1097/00007890-198812000-00013.
STING1 deficiency ameliorates immune-mediated crescentic glomerulonephritis in mice.
García-Giménez J, Córdoba-David G, Rayego-Mateos S, Cannata-Ortiz P, Carrasco S, Ruiz-Ortega M, Fernandez-Fernandez B, Ortiz A, Ramos AM.
J Pathol. 2023 Nov;261(3):309-322. doi: 10.1002/path.6177. Epub 2023 Aug 31.
Crescentic Glomerulonephritis: an update on Pauci-immune and Anti-GBM diseases.
Kambham N.
Adv Anat Pathol. 2012 Mar;19(2):111-24. doi: 10.1097/PAP.0b013e318248b7a1.
Clinical and immunological evolution of oligoanuric anti-GBM nephritis treated by haemodialysis.
Flores JC, Taube D, Savage CO, Cameron JS, Lockwood CM, Williams DG, Ogg CS.
Lancet. 1986 Jan 4;1(8471):5-8. doi: 10.1016/s0140-6736(86)91893-3.
